MedTrace Logo

Influence of Central Obesity on the Esophageal Epithelial Barrier

NCT02776982 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2022-02-09

No results posted yet for this study

Summary

This study is being done to help understand why some people with an increased amount of central obesity, without gastroesophageal reflux, develop changes to the lining of their esophagus that can potentially lead to esophageal adenocarcinoma (cancer).

Conditions

  • Gastroesophageal Reflux
  • GERD

Interventions

PROCEDURE

Confocal endomicroscopy

Confocal endomicroscopy will be performed during clinically indicated endoscopy.

PROCEDURE

Mucosal impedance

Mucosal impedance will be performed at the time of clinically indicated endoscopy.

PROCEDURE

Research biopsies

Research biopsies will be obtained during clinically indicated endoscopy.

PROCEDURE

Bravo ambulatory pH monitor

Bravo ambulatory pH capsule will be placed during clinically indicated endoscopy.

Sponsors & Collaborators

Principal Investigators

  • Prasad G Iyer, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2019-05-16
Completion
2019-05-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02776982 on ClinicalTrials.gov